Physician profile
Mayo Friedlis
NPI 1487621462
$1,964.85
in general payments reported to CMS, 2019-2025
20 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $177 · 2021: $201 · 2022: $546 · 2023: $53.09 · 2024: $223 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $322.70 | 2021-2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $206.55 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Foundation Fusion Solutions, LLC | $191.67 | 2022 | |
| Pacira Therapeutics, INC. | $189.07 | 2019 | |
| Abbott Laboratories | $177.69 | 2022 | |
| Biotronik Nro, INC. | $143.23 | 2025 | Prospera |
| Grt US Holding, INC. | $130.00 | 2022 | |
| Merz North America, INC. | $123.91 | 2020 | |
| Lilly USA, LLC | $92.85 | 2019 | |
| Medtronic USA, INC. | $85.20 | 2019 | |
| Fidia Pharma USA INC. | $67.93 | 2022-2024 | Hymovis |
| Pacira Pharmaceuticals Incorporated | $47.50 | 2023-2025 | Zilretta, Iovera, Exparel |
| Arteriocyte Medical Systems, INC. | $40.61 | 2020 | |
| Bioventus LLC | $32.80 | 2020-2021 | |
| Si-Bone, INC. | $28.86 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $27.64 | 2024 | |
| Averitas Pharma INC. | $19.35 | 2023 | Qutenza |
| Scilex Pharmaceuticals INC. | $18.66 | 2019 | |
| Biodelivery Sciences International, INC. | $12.78 | 2019 | |
| Mml US, INC. | $5.85 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayo Friedlis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.